期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血脑屏障与药物转运研究近况

暂未订购
导出
摘要 重组蛋白、单克隆抗体、反义寡核苷酸等许多蛋白质或多肽均有中枢神经活性，但因为血脑屏障（blood-brain banffer。BBB）阻碍了这些物质进入脑中，因此跨血脑屏障的药物转运研究日益活跃。
作者 全晓雯
机构地区 昆明医学院第一附属医院药剂科
出处 《中国药师》 CAS 2007年第3期281-282,共2页 China Pharmacist
关键词 血脑屏障 药物转运
分类号 R945 [医药卫生—微生物与生化药学]
  • 相关文献

参考文献7

  • 1Varma MY,Ashokraj Y,Dey CS.P-glycoprotein inhibitors and their screening:a perspective from bioavilability enhancement[J].Pharmacological Rcscarch,2003,48 (4):347
  • 2吴云娟,方晓玲.P-糖蛋白在药物脑部转运中作用的研究进展[J].中国临床药学杂志,2004,13(6):382-385. 被引量：5
  • 3Bickel U,Yoshikawa T,Pardridge WM.Delivery of peptides adproteins through the blood-brain barrier[J].Adv Drug Deli Rev,2001,46:247
  • 4Bodor N,Buchwald P.Recent advances in the braintargeting of neuropharmaceuticals by chemjcal delivery system[J].Adv Drug Del Rev,1999,36 (2-3):229-254
  • 5Sun HY,Dai HQ,Shaik N,et al.Drug efflux transporters in the CNS[J].Adv Drug Deliv Rev,2003,55(1):83
  • 6安富荣,陶涛.中枢神经系统给药方法研究进展[J].国外医药（合成药．生化药．制剂分册）,2000,21(4):241-244. 被引量：10
  • 7Chen D,Lee KH.Biodistribution of calcition in encapsulated in liposomes in mice with particalar reference to the central nervous system[J].Biochim Biophys Acta Gen Subj,1993,1158(3):244-250

二级参考文献27

  • 1Letrent SP, Pollack GM, Brouwer KR, et al. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat[J]. Drug Metab Dispos,1999,27(7) :827.
  • 2Seegers U,Potschka H,Looscher W. Transient increase of P-glyeoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy[J]. Eilepsy Resarch, 2002, 51(3) :257.
  • 3Reinhardt CA, Gloor SM. Co-culture blood-brain barrier models and their use for pharmatoxicologial screening[J] .Toxicol in Vitro, 1997,11(5):513.
  • 4Zhang Y, Bachmeier C, Miller DW, In vitro and in vivo models for assessing drug efflux transporter activity[J]. Adv Drug Delivery Rev,2003,55(1) :31.
  • 5Fromm MF. The influence of MDR 1 polmyorphisms on P-glycprotein expression and function in humans[J]. Adv Drug Deliv Rev,2002,54(10): 1295.
  • 6Lin JH. Drug-drug interaction mediated by inhibition and induction of Pglycoprotein[ J]. Adv Drug Deliv Rev,2003,55(1):53.
  • 7Varma MV, Ashodraj Y, Dey CS. P-glycoprotein inhibitors and their screening:a perspective from bioavailability enhancement[J]. Pharmacological Research,2003,48(4) :347.
  • 8Dantzing AH, Alwis DPD, Burgess M. Consideration in the design and development of transport[J] ,Adv Drug Deliv Rev,2003,55(1):133.
  • 9Kabanov AV, Batrakova EV, Miller DW. Pluronic R block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier [J].Adv Drug Deliv Rev,2003,55(1): 151.
  • 10Desrayaud S,Guntz P,Xie L, et al..Effect of the P-glyccoprrotein inhibitor, SDZ, PSC 833, on the blood and brain pharmaceutics of colchicines[J]. Life Sci, 1997,61 (2): 153.

共引文献13

中国药师
2007年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部